Tonghua Golden-horse Pharmaceutical Industry Co Ltd - Class A

SZSE:000766 (China)   Class A
¥ 15.76 (-1.56%) Apr 18
477.58
P/B:
6.57
Market Cap:
¥ 15.23B ($ 2.10B)
Enterprise V:
¥ 16.99B ($ 2.35B)
Volume:
19.39M
Avg Vol (2M):
44.83M
Volume:
19.39M
Avg Vol (2M):
44.83M

Business Description

Tonghua Golden-horse Pharmaceutical Industry Co Ltd
NAICS : 325199 SIC : 2833
ISIN : CNE000000735

Share Class Description:

SZSE:000766: Class A
Description
Tonghua Golden-horse Pharmaceutical Industry Co Ltd is a pharmaceutical company engaged in the manufacturing and sale of pharmaceutical products. It is a comprehensive pharmaceutical company integrating the production, sales, and research and development of pharmaceuticals. Tonghua's products mainly focus on rheumatism, bone diseases, digestion, tumors, and gynecology and distributing it mainly in the eastern part of China.
Name Current Vs Industry Vs History
Cash-To-Debt 0.11
Equity-to-Asset 0.52
Debt-to-Equity 0.73
Debt-to-EBITDA 12.83
Interest Coverage 1.48
Piotroski F-Score 6/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.44
Distress
Grey
Safe
Beneish M-Score -2.6
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 31.14
9-Day RSI 34.86
14-Day RSI 39.53
6-1 Month Momentum % 16.11
12-1 Month Momentum % 232.51

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.05
Quick Ratio 1.3
Cash Ratio 0.35
Days Inventory 387.76
Days Sales Outstanding 98.66
Days Payable 210.2

Dividend & Buy Back

Name Current Vs Industry Vs History
Shareholder Yield % 0.65
Income Statement Breakdown
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Tonghua Golden-horse Pharmaceutical Industry Co Ltd Executives

Details

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil ¥) 1,501.238
EPS (TTM) (¥) 0.033
Beta 0.64
Volatility % 85.51
14-Day RSI 39.53
14-Day ATR (¥) 0.95649
20-Day SMA (¥) 17.7015
12-1 Month Momentum % 232.51
52-Week Range (¥) 4.53 - 24.51
Shares Outstanding (Mil) 966.49

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Tonghua Golden-horse Pharmaceutical Industry Co Ltd Filings

Filing Date Document Date Form
No Filing Data

Tonghua Golden-horse Pharmaceutical Industry Co Ltd Stock Events

Financials Calendars
Event Date Price(¥)
No Event Data

Tonghua Golden-horse Pharmaceutical Industry Co Ltd Frequently Asked Questions

What is Tonghua Golden-horse Pharmaceutical Industry Co Ltd(SZSE:000766)'s stock price today?
The current price of SZSE:000766 is ¥15.76. The 52 week high of SZSE:000766 is ¥24.51 and 52 week low is ¥4.53.
When is next earnings date of Tonghua Golden-horse Pharmaceutical Industry Co Ltd(SZSE:000766)?
The next earnings date of Tonghua Golden-horse Pharmaceutical Industry Co Ltd(SZSE:000766) is .
Does Tonghua Golden-horse Pharmaceutical Industry Co Ltd(SZSE:000766) pay dividends? If so, how much?
Tonghua Golden-horse Pharmaceutical Industry Co Ltd(SZSE:000766) does not pay dividend.

Press Release

Subject Date
No Press Release